Generic Ribavirin Label “Carve Out” Permitted; FDA Denies ICN Petition

Generic ribavirin labeling can omit information on combination use with PEG-Intron, FDA said

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet